Adding heft to diplomacy with some help from science
Updated:
Updated:
February 23, 2021 13:12 IST
The pandemic gives India a unique space to mainstream science and technology in its domestic and foreign policies
Share Article
AAA
The pandemic gives India a unique space to mainstream science and technology in its domestic and foreign policies
India’s ongoing ‘Vaccine Maitri’ campaign, which is aimed at provisioning COVID-19 vaccines to countries both near to and away from its immediate neighborhood, is one of the most important recent initiatives to leverage its science and technological advantages for the furtherance of its foreign policy objectives. While the appreciation of leaders such as President Jair Bolsonaro of Brazil and the reluctant outreach of Canadian Prime Minister Justin Trudeau for securing vaccines manufactured in India have gained much attention, New Delhi’s efforts to address this health emergency were met with even more vocal appreciation by lea
Bayer partners with Arogya Finance
indiagazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiagazette.com Daily Mail and Mail on Sunday newspapers.
Bayer partners with Arogya Finance to provide Eylea Easy Pay Program in India
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Bayer offers affordable payment solutions for Eylea treatment
Bayer offers affordable payment solutions for Eylea treatment
22 December 2020 | News Bayer’s Eylea is used for the treatment for both Wet AMD, which affects the elderly population and DME, which affects diabetics.
Source credit: Shutterstock
Bayer has announced its collaboration with social healthcare venture Arogya Finance to introduce the Eylea Easy Pay Programme in India to provide flexible and affordable payment solutions to help patients in India access Eylea (aflibercept solution) treatment.
Through this partnership, Bayer and Arogya Finance have increased the accessibility of the innovative treatment solutions, thus reducing the immediate financial burden on patients and their families.